Top Medicine journals
8,757 ranked journals whose recent papers are mostly in Medicine, compared only with each other.
| Rank | Journal | Score | Papers 2021–2025 | h-index | 2-yr mean citedness | Open access |
|---|---|---|---|---|---|---|
| #1 | New England Journal of Medicine Massachusetts Medical Society | 98.0 | 5,340 | 1,512 | 31.3 | 31% |
| #2 | The Lancet Elsevier BV | 96.9 | 7,837 | 1,211 | 20.4 | 47% |
| #3 | Cancer Cell Cell Press | 94.3 | 992 | 487 | 33.8 | 66% |
| #4 | Signal Transduction and Targeted Therapy Springer Nature | 94.3 | 2,113 | 285 | 49.7 | 100% |
| #5 | Cell Metabolism Cell Press | 94.1 | 990 | 455 | 29.3 | 68% |
| #6 | Nature reviews. Cancer Nature Portfolio | 93.3 | 575 | 600 | 25.5 | 25% |
| #7 | The Lancet Neurology Elsevier BV | 92.4 | 1,381 | 458 | 17.3 | 39% |
| #8 | Diabetes Care American Diabetes Association | 91.8 | 2,264 | 511 | 13.2 | 86% |
| #9 | JAMA American Medical Association | 91.8 | 8,958 | 1,015 | 9.2 | 27% |
| #10 | Nature Reviews Clinical Oncology Nature Portfolio | 91.5 | 646 | 287 | 28.0 | 20% |
| #11 | The Lancet Oncology Elsevier BV | 91.4 | 2,390 | 524 | 12.0 | 29% |
| #12 | Journal of Clinical Investigation American Society for Clinical Investigation | 91.3 | 3,060 | 714 | 10.4 | 100% |
| #13 | MMWR Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention | 91.2 | 1,406 | 254 | 19.3 | 100% |
| #14 | Journal of Hematology & Oncology BioMed Central | 91.1 | 757 | 234 | 33.8 | 100% |
| #15 | Kidney International Elsevier BV | 90.8 | 2,272 | 392 | 12.7 | 52% |
| #16 | The Lancet Infectious Diseases Elsevier BV | 90.5 | 2,798 | 375 | 11.7 | 52% |
| #17 | Nature Reviews Disease Primers Nature Portfolio | 90.0 | 439 | 278 | 37.3 | 35% |
| #18 | Gut BMJ | 89.7 | 1,665 | 454 | 11.0 | 52% |
| #19 | Ageing Research Reviews Elsevier BV | 89.6 | 1,395 | 227 | 16.2 | 43% |
| #20 | The Lancet Diabetes & Endocrinology Elsevier BV | 89.5 | 1,017 | 249 | 17.0 | 43% |
| #21 | Cardiovascular Diabetology BioMed Central | 89.2 | 1,842 | 170 | 17.0 | 100% |
| #22 | Heliyon Elsevier BV | 89.2 | 38,508 | 190 | 9.1 | 100% |
| #23 | Brain Oxford University Press | 89.0 | 2,360 | 505 | 8.5 | 87% |
| #24 | Nature Reviews Cardiology Nature Portfolio | 88.8 | 741 | 250 | 17.3 | 27% |
| #25 | Physiological Reviews American Physiological Society | 88.4 | 218 | 565 | 22.7 | 74% |
| #26 | Nature Reviews Neurology Nature Portfolio | 88.3 | 728 | 271 | 15.5 | 25% |
| #27 | Nature Reviews Gastroenterology & Hepatology Nature Portfolio | 88.3 | 763 | 262 | 15.5 | 24% |
| #28 | CA A Cancer Journal for Clinicians Wiley | 88.2 | 295 | 269 | 225.2 | 100% |
| #29 | JAMA Psychiatry American Medical Association | 88.2 | 1,165 | 257 | 13.0 | 69% |
| #30 | Nutrients Multidisciplinary Digital Publishing Institute | 88.1 | 23,506 | 331 | 6.2 | 100% |
| #31 | Nature Reviews Nephrology Nature Portfolio | 88.0 | 648 | 225 | 17.5 | 32% |
| #32 | Antioxidants Multidisciplinary Digital Publishing Institute | 88.0 | 9,811 | 207 | 8.8 | 100% |
| #33 | Cochrane Database of Systematic Reviews Elsevier BV | 88.0 | 2,873 | 461 | 7.3 | 94% |
| #34 | European Respiratory Journal European Respiratory Society | 87.9 | 2,030 | 359 | 8.8 | 68% |
| #35 | Nature Metabolism Nature Portfolio | 87.7 | 1,094 | 149 | 17.8 | 56% |
| #36 | Hepatology Lippincott Williams & Wilkins | 87.7 | 2,665 | 481 | 7.0 | 38% |
| #37 | The Lancet Respiratory Medicine Elsevier BV | 87.7 | 1,472 | 257 | 11.1 | 58% |
| #38 | The Lancet Global Health Elsevier BV | 87.7 | 2,009 | 221 | 11.1 | 100% |
| #39 | JAMA Neurology American Medical Association | 87.6 | 1,277 | 235 | 12.2 | 59% |
| #40 | Nature Reviews Endocrinology Nature Portfolio | 87.6 | 764 | 265 | 13.9 | 27% |
| #41 | npj Digital Medicine Nature Portfolio | 87.6 | 1,879 | 168 | 13.3 | 100% |
| #42 | EBioMedicine Elsevier BV | 87.3 | 2,863 | 181 | 10.9 | 100% |
| #43 | Radiology Radiological Society of North America | 87.1 | 3,473 | 432 | 6.3 | 31% |
| #44 | Cancer Discovery American Association for Cancer Research | 87.1 | 2,477 | 303 | 8.0 | 46% |
| #45 | Clinical Infectious Diseases Oxford University Press | 87.0 | 4,280 | 486 | 5.8 | 77% |
| #46 | EClinicalMedicine Elsevier BV | 87.0 | 2,975 | 150 | 12.0 | 100% |
| #47 | The Lancet Public Health Elsevier BV | 86.9 | 873 | 156 | 16.7 | 100% |
| #48 | The Journal of Clinical Endocrinology & Metabolism Oxford University Press | 86.9 | 4,116 | 491 | 5.6 | 76% |
| #49 | Circulation Research Lippincott Williams & Wilkins | 86.9 | 3,626 | 507 | 5.7 | 31% |
| #50 | American Journal of Psychiatry American Psychiatric Association | 86.7 | 845 | 555 | 8.0 | 35% |
| #51 | Critical Care BioMed Central | 86.7 | 2,466 | 289 | 7.7 | 100% |
| #52 | Drugs Adis, Springer Healthcare | 86.6 | 804 | 262 | 11.7 | 63% |
| #53 | BMC Medicine BioMed Central | 86.6 | 2,714 | 259 | 7.9 | 100% |
| #54 | The Lancet. Gastroenterology & hepatology Elsevier BV | 86.5 | 1,288 | 172 | 12.5 | 33% |
| #55 | PLoS Medicine Public Library of Science | 86.5 | 1,100 | 351 | 8.6 | 100% |
| #56 | Endocrine Reviews Oxford University Press | 86.4 | 196 | 428 | 20.4 | 86% |
| #57 | Nature Reviews Rheumatology Nature Portfolio | 86.4 | 778 | 235 | 12.3 | 23% |
| #58 | Nature Cancer Nature Portfolio | 86.4 | 919 | 133 | 17.0 | 51% |
| #59 | Journal of Translational Medicine BioMed Central | 86.3 | 4,844 | 192 | 8.0 | 100% |
| #60 | Diabetologia Springer Science+Business Media | 86.2 | 1,325 | 338 | 7.9 | 93% |
| #61 | Acta Neuropathologica Springer Science+Business Media | 86.2 | 710 | 290 | 10.9 | 89% |
| #62 | Life Sciences Elsevier BV | 86.1 | 4,315 | 289 | 6.4 | 21% |
| #63 | PEDIATRICS American Academy of Pediatrics | 86.1 | 4,618 | 519 | 4.9 | 35% |
| #64 | JAMA Internal Medicine American Medical Association | 86.1 | 2,258 | 258 | 7.7 | 47% |
| #65 | Molecular Neurodegeneration BioMed Central | 86.1 | 499 | 168 | 18.1 | 100% |
| #66 | JAMA Oncology American Medical Association | 86.0 | 1,919 | 247 | 8.2 | 50% |
| #67 | Clinical Microbiology Reviews American Society for Microbiology | 86.0 | 223 | 422 | 17.6 | 100% |
| #68 | Annals of Internal Medicine American College of Physicians | 86.0 | 3,292 | 652 | 4.8 | 17% |
| #69 | British Journal of Cancer Springer Nature | 86.0 | 2,088 | 347 | 6.7 | 99% |
| #70 | Sports Medicine Springer Science+Business Media | 86.0 | 1,027 | 319 | 8.6 | 65% |
| #71 | Metabolism Elsevier BV | 85.8 | 1,400 | 239 | 8.8 | 30% |
| #72 | Journal of Neurology Neurosurgery & Psychiatry BMJ | 85.7 | 1,777 | 339 | 6.7 | 33% |
| #73 | Intensive Care Medicine Springer Science+Business Media | 85.6 | 1,927 | 315 | 6.8 | 63% |
| #74 | Emerging infectious diseases Centers for Disease Control and Prevention | 85.6 | 2,606 | 330 | 6.2 | 100% |
| #75 | Cancers Multidisciplinary Digital Publishing Institute | 85.5 | 26,937 | 223 | 5.1 | 100% |
| #76 | Frontiers in Pharmacology Frontiers Media | 85.4 | 20,808 | 241 | 5.0 | 100% |
| #77 | Trends in Endocrinology and Metabolism Elsevier BV | 85.4 | 645 | 243 | 11.2 | 45% |
| #78 | Journal of Affective Disorders Elsevier BV | 85.3 | 8,118 | 309 | 5.0 | 41% |
| #79 | American Journal of Clinical Nutrition Elsevier BV | 85.3 | 2,044 | 500 | 5.2 | 62% |
| #80 | Annals of Surgery Lippincott Williams & Wilkins | 85.3 | 2,281 | 456 | 5.3 | 38% |
| #81 | PLoS ONE Public Library of Science | 85.2 | 85,051 | 603 | 3.2 | 100% |
| #82 | BMC Public Health BioMed Central | 85.2 | 15,854 | 291 | 4.6 | 100% |
| #83 | Archives of Pediatrics and Adolescent Medicine American Medical Association | 85.1 | 1,867 | 299 | 6.5 | 56% |
| #84 | Stem Cell Research & Therapy BioMed Central | 84.9 | 2,796 | 176 | 7.8 | 100% |
| #85 | The Lancet Digital Health Elsevier BV | 84.9 | 671 | 130 | 16.0 | 100% |
| #86 | The American Journal of Sports Medicine SAGE Publishing | 84.6 | 2,173 | 362 | 5.4 | 28% |
| #87 | Leukemia Springer Nature | 84.6 | 1,729 | 259 | 6.7 | 76% |
| #88 | Autophagy Taylor & Francis | 84.6 | 1,321 | 241 | 7.5 | 100% |
| #89 | Clinical Gastroenterology and Hepatology Elsevier BV | 84.6 | 2,830 | 263 | 5.8 | 47% |
| #90 | Journal of Nuclear Medicine Society of Nuclear Medicine and Molecular Imaging | 84.5 | 2,100 | 228 | 6.7 | 73% |
| #91 | British Journal of Sports Medicine BMJ | 84.5 | 1,359 | 313 | 6.4 | 61% |
| #92 | Cancer Wiley | 84.4 | 3,027 | 474 | 4.4 | 72% |
| #93 | Journal of Virology American Society for Microbiology | 84.4 | 3,332 | 422 | 4.5 | 100% |
| #94 | Annals of Neurology Wiley | 84.4 | 1,538 | 440 | 5.2 | 70% |
| #95 | Modern Pathology Elsevier BV | 84.1 | 1,151 | 213 | 7.9 | 90% |
| #96 | Journal of the American Heart Association Wiley | 84.1 | 5,909 | 200 | 5.6 | 100% |
| #97 | International Journal of Environmental Research and Public Health Multidisciplinary Digital Publishing Institute | 84.0 | 41,142 | 321 | 3.5 | 100% |
| #98 | Cell Reports Medicine Elsevier BV | 84.0 | 1,766 | 104 | 11.9 | 100% |
| #99 | Psychological Medicine Cambridge University Press | 83.9 | 2,098 | 333 | 5.1 | 86% |
| #100 | Allergy Wiley | 83.9 | 2,258 | 252 | 5.7 | 72% |
Other journal rankings
Looking for a journal for your paper? Use the journal finder.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.